8 December 2020.
POSTED 8 December 2020.
GeneDetect® announces extension to its major alliance with leading European
Pharmaceutical and Diagnostics Company to perform contract gene
expression and biomarker validation assays. GeneDetect to receive
upfront payment and equity investment.
Friday February 10, 8:00am ET
Auckland (BUSINESS WIRE) February 10, 2016. GeneDetect (Sarasota, Florida and Auckland, New Zealand), a leading supplier of products and services to academic and government research institutions as well as pharmaceutical and biotechnology companies, announced today that it
has entered into a 5 year extension of its major alliance with a leading European Pharmaceutical
and Diagnostic company (THE COMPANY) to perform gene expression
and biomarker validation assays. The 5 year extension will last until at
least January 2021. GeneDetect will receive an additional upfront payment and equity investment
as part of the extended alliance.
POSTED 10 January 2011.
GeneDetect is pleased to announce the opening of a new facility in
Sarasota, Florida. This new facility will allow the company to meet
increased customer demand from 2011 onwards.
GeneDetect announced today the opening of its new headquarters in
Sarasota, Florida. From the 10th of January 2011 onwards, GeneDetect has
relocated to a larger and newer facility located at 4281 Express Lane, Suite L8299, Sarasota, FL
Older customers will remember our original facility was also located in
Sarasota. Please update your records. Our full contact details can be
found here: Contact Us.
POSTED 8 September 2007
GeneDetect announces major alliance with leading European Pharmaceutical and Diagnostics Company to perform contract gene expression and biomarker validation assays. GeneDetect to receive upfront payment and equity investment.
GeneDetect announced today that it has entered into a major alliance with a leading European Pharmaceutical and Diagnostic company to perform gene expression and biomarker validation assays. The
4 year contract will last until at least September 2011. GeneDetect will receive an upfront payment and equity investment as part of the alliance.
The popular branded GeneDetect® and GreenStar hyperlabeled gene probe product ranges are used to measure gene expression in tissue samples. "The GeneDetect® and GreenStar hyperlabeled gene probe product ranges are used worldwide everyday by researchers in leading research institutes and companies for this purpose and are widely cited in the literature in leading scientific journals" said GeneDetect Chairman and Chief Executive Officer Dr Paul E Hughes. "It is a natural progression then that we begin to work closely with major Pharmaceutical companies on biomarker validation. While we are focused on this major alliance we will ensure all current customers and projects remain fully supported. However since this major alliance will consume most of our production and screening capacity during this time we will be unable to accept new customers and enquiries and we apologize in advance for any inconvenience this may
POSTED 12 December 2005
Roche Diagnostics GmbH and GeneDetect finalize worldwide licensing
Dr Paul Hughes, CEO of
GeneDetect. "Today I am happy to announce that GeneDetect has
negotiated a broad license to the valuable Roche Diagnostics GmbH,
Digoxigenin/Digoxin patent portfolio for the detection of nucleic
acids. This license will allow GeneDetect to release a range of new
products incorporating Digoxigenin/Digoxin. We expect these products to
become available early in 2006".
POSTED 16 January 2005
Track the delivery of your orders from our tracking page.
You can now track the
delivery of your orders online, direct from our website. Please track your
POSTED 9 July 2004
Updated 2004-2005 Catalog available.
Our 2004-2005 catalog is now available for download. Download
POSTED 16 September 2003
Registration of GeneDetect® trademark approved.
Today the US Patent and
Trademark Office approved registration of the GeneDetect trademark (Reg.
2765935). "This protects the brand we have developed and enables our
customers to more easily identify and differentiate our products in the
marketplace" said Dr Paul
Hughes, CEO of GeneDetect.
POSTED 25 July 2003
Successful licensing of Syngene "In situ Hybridization"
patents completed. Dr Paul
Hughes, CEO of GeneDetect stated, "Today I am pleased to announce
that we have successfully completed licensing negotiations with Syngene
Limited, Australia. The Syngene "In situ Hybridization"
patents licensed include US Patents 5,597,692 and 6,265,156, European
Patent 0,175,776, Canadian Patent 1,251,119, Australian Patent 579,631 and
Japanese Patent 1,970,487. The terms of the licensing agreement will
strengthen our position as "the world's largest selection of gene
probes" and will secure an important competitive
advantage for GeneDetect which is the ability to supply researchers with
our highly sensitive
GreenStar hyperlabeled gene probe range for use with in situ hybridization".
POSTED 7 May 2003
Updated 2003 Catalog available.
Our 113 page 2003 catalog is now available for download. Download
POSTED 4 April 2003.
GeneDetect announces the opening of its North American headquarters in Florida. Dr Paul
Hughes, CEO of GeneDetect stated, "I am pleased to announce the
opening of our North American operations today. I believe having
headquarters based in the US will allow us to better pursue the
opportunities offered and better service our customers located in the
North American market".
POSTED 11 December 2002.
PRESS RELEASE. GeneDetect experiences rapid year-on-year revenue
has significantly exceeded its Q1-Q3 revenue targets for 2002. On the
basis of preliminary consolidated results, worldwide revenue due mainly to
Gene Probe sales of its popular GreenStar range have grown some 300 percent
as compared to the first three quarters of the previous year. Performance
in 2003 is expected to show similar rapid growth with the addition of
income generated by the sale of rAVE vectors, riboprobe templates and
expansion into custom peptide manufacture.
POSTED 24 September 2002.
New Distributor appointed. GeneDetect is very
to announce the appointment of bioFrontier Technology
as exclusive distributors of its product range in Singapore. For full contact details click
POSTED 2 September 2002.
Receive personal "Amazon.com
Gift Certificates" when you order two or more GreenStar DIG, Biotin or
FITC labeled and custom designed probes. Custom probes can be
prepared to detect any target gene of interest as long as the gene
sequence is known. Click
here for further details.
POSTED 5 August
rAVETM gene delivery reagents. Express your gene of interest in
any cell type in vitro or in vivo. rAVE gene delivery reagents are ideal
for functional genomic and gene therapy studies and are produced in
consultation with a world-leading academic research group. For more details click
POSTED 17 July
New Distributor appointed. GeneDetect is
to announce the appointment of MedPro (website, http://www.medpro-wien.at)
as exclusive distributors of its product range in Austria. For full contact details click
POSTED 17 July 2002.
GeneDetect reaches agreement with Auckland UniServices Limited to
exclusively distribute AAV-2 (rAVETM) gene delivery reagents to
its worldwide customer base. GeneDetect is pleased to
announce today the successful completion of negotiations with Auckland
UniServices Limited for the exclusive worldwide distribution rights for
AAV-2 gene delivery reagents developed within the University of Auckland
Matthew During a leading expert in gene therapy and gene delivery
techniques. Auckland UniServices Limited is a company owned by The
University of Auckland and set up to facilitate research, consulting and
technology transfer (Website, http://www.uniservices.co.nz). Dr Paul
Hughes, CEO of GeneDetect stated, "I am pleased to finalize our
negotiations with Auckland UniServices Limited. I hope this will be the
first of many such agreements between the two companies. The University of
Auckland has many other high quality research reagents that we believe we
can effectively promote and distribute to the NZD $16 billion global life
POSTED 1 July 2002
ONE-STEP custom RNA probe synthesis templates featuring T3/T7 or SP6 OptiScriptTM
promoters allow for direct in vitro transcription of optimized 80mer riboprobes
to ANY target gene. No more sub-cloning or plasmid preps. Add water to
dilute the template and then transcribe your riboprobe using your favorite
in vitro transcription kit. For more details click here.
POSTED 6 May 2002
Updated 2002 Catalog available. Our 80 page 2002 catalog is now available for download.
POSTED 2 May 2002
Receive a personal "Amazon.com
Gift Certificate" when you order two or more GreenStar DIG, Biotin or
FITC labeled probes. Click
here for details.
POSTED 3 March 2002.
Promotion. Receive up to USD$80 of personal Amazon.com Gift Certificates simply by
using a credit card to pay for your order!! Click
here for details.
14 February 2002.
Commercialize your research reagents and/or technology. GeneDetect
announces its Research commercialization program. Find out all the details.
4 February 2002.
Real-time multi-currency pricing is now available for you to try on our
website. Multi-currency invoicing is also now available. Settlement by
credit card is currently limited to US dollars, Euros, Pounds
Sterling or Japanese Yen.
POSTED 3 February 2002.
On request we custom designed a decoy for the MeCP2 transcriptional
repressor implicated in Rett Syndrome. Read about this
Learn more about Rett Syndrome.
25 January 2002.
GET eQUOTES AND MAKE ORDERS IN YOUR OWN CURRENCY: Understanding the
global nature of our customers, we are happy to announce that full
multi-currency functionality will be incorporated into our website by the
end of February. By selecting your currency from a drop down list you will
receive real-time conversion of product prices from USD to your selected
currency. This will allow you to generate eQuotes or make orders fully in
your own preferred currency. We will also begin invoicing in currencies
other than USD to complement these changes. We hope this alleviates
some of the issues our non US-based customers have faced in the past.
1 January 2002
Promotion: Earn personal Amazon.com gift certificates when you make a
purchase in January. Find out how.
5 Dec 2001
We are happy to announce that COSMO BIO Co., Ltd will act as our distributors for
JAPAN and Jingmei Biotech Co., Ltd as our distributors for CHINA. For
contact details click here.
17 Sep 2001
GENEDETECT Transcription Factor Decoys profiled in "The-Scientist"
POSTED, 1 June
Available NOW GreenStar* probes
Links for other
news stories coming soon.